(Life Sciences) received an NIH/NV-INBRE Developmental Research Project (DRP) award to study how Pseudomonas aeruginosa, a bacterial pathogen that causes lung infections in immuno-compromised humans, forms antibiotic-resistant aggregates. The DRP award is for up to two years and a total amount of $223,000.